Omnicell Stock

Omnicell P/S 2024

Omnicell P/S

1.28

Ticker

OMCL

ISIN

US68213N1090

WKN

632313

As of Nov 6, 2024, Omnicell's P/S ratio stood at 1.28, a -55.4% change from the 2.87 P/S ratio recorded in the previous year.

The Omnicell P/S history

Omnicell Aktienanalyse

What does Omnicell do?

Omnicell Inc. is a leading company in the healthcare industry, specializing in the development and provision of innovative automation solutions for medication and other critical medical supplies. The company was founded in 1992 and is headquartered in Mountain View, California, USA. Over the years, Omnicell has grown into a global company with offices in North America, Europe, Asia, and the Middle East. Omnicell's business model is to offer products, services, and solutions that allow healthcare facilities to optimize their processes, increase patient safety, and save costs. Omnicell provides innovative automation solutions, particularly for medication management, sterilization, and inventory control. Omnicell offers various solutions to improve medication management in clinics. This includes, for example, the medication cabinet, which has an integrated computer system that allows for the quick and easy identification and retrieval of needed medications. Omnicell also offers solutions for sterilizing medical materials to ensure patient safety, as well as automated storage systems for managing medical supplies. In recent years, the company has focused heavily on developing solutions to improve patient safety. One example is Omnicell's Medical Intelligence platform, which automatically detects and notifies of medication errors and other issues, thereby enhancing patient safety. Omnicell's products are used by a wide range of healthcare facilities, from small doctor's offices to large hospitals and health centers. The company has also established relationships with major retailers to sell its products, such as CVS and Walgreens in the USA. In addition to its core products and services, Omnicell also provides training and support to customers to ensure they can make optimal use of their products. The company also has its own research and development department to continuously develop new and innovative products and solutions. Overall, Omnicell aims to transform the healthcare industry through innovative automation solutions. Through its products, services, and solutions, the company has already helped many healthcare facilities improve their processes and increase patient safety. Omnicell will continue to invest in the development of new products and technologies to optimize the healthcare industry in the long term. Omnicell ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Omnicell's P/S Ratio

Omnicell's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Omnicell's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Omnicell's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Omnicell’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Omnicell stock

What is the price-to-earnings ratio of Omnicell?

The price-earnings ratio of Omnicell is currently 1.28.

How has the price-earnings ratio of Omnicell changed compared to last year?

The price-to-earnings ratio of Omnicell has increased by -55.4% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Omnicell high compared to other companies?

Yes, the price-to-earnings ratio of Omnicell is high compared to other companies.

How does an increase in the price-earnings ratio of Omnicell affect the company?

An increase in the price-earnings ratio of Omnicell would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Omnicell affect the company?

A decrease in the price-earnings ratio of Omnicell would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Omnicell?

Some factors that influence the price-earnings ratio of Omnicell are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Omnicell pay?

Over the past 12 months, Omnicell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Omnicell is expected to pay a dividend of 0 USD.

What is the dividend yield of Omnicell?

The current dividend yield of Omnicell is .

When does Omnicell pay dividends?

Omnicell pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Omnicell?

Omnicell paid dividends every year for the past 0 years.

What is the dividend of Omnicell?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Omnicell located?

Omnicell is assigned to the 'Health' sector.

Wann musste ich die Aktien von Omnicell kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Omnicell from 11/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Omnicell pay the last dividend?

The last dividend was paid out on 11/6/2024.

What was the dividend of Omnicell in the year 2023?

In the year 2023, Omnicell distributed 0 USD as dividends.

In which currency does Omnicell pay out the dividend?

The dividends of Omnicell are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Omnicell

Our stock analysis for Omnicell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Omnicell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.